SULT2A1 and congenital adrenal hyperplasia: The limited number of included patients with CAH, but still a decent size compared to previous studies [12, 26], the wide age range, only few males, not having access to the total glucocorticoid and androgen exposure during the entire life as well as the economic constraints preventing us from analyzing more biochemical tests such as androstenedione and DHEAS were some of them.